Subsequently, here we demonstrate that indeed Rab25 levels are selectively elevated in luminal B breast cancers and surprisingly suppressed in a subset of basal-like breast cancer, namely the claudin-low tumors (sometimes referred as basal B), partly due to increased genomic methylation of the Rab25 promoter region. This evidence concerns the gene RAB25 and breast cancer.